A drug-like compound could be a game-changer in the fight against glioblastoma. "We haven't found a single brain cancer cell line that it can't kill."

Glioblastoma is one of the most treatment-resistant cancers. A new study offers clues as to how it can aggressively resist immunotherapy.

Glioblastoma is the most aggressive type of brain cancer, causing significant decline in cognitive function. New research suggests a common anti-seizure drug could help control tumor growth.

A newly-developed nanoparticle offers a more effective way to deliver a chemotherapy drug to fast growing, aggressive brain tumors.

A new fluorescent dye that lights up the brain holds promise for cancer treatment, according to new research.

Scientists at Harvard-affiliated Brigham and Women’s Hospital have developed a cancer vaccine to simultaneously kill and prevent brain cancer in advanced mouse models.

"This personalized immune therapy could be a game-changer for a disease this is so deadly and difficult to treat."

A new way to get drugs across the blood-brain barrier in mice could one day lead to a way to treat humans with brain cancer.

Researchers have found a process in glioblastoma brain tumors that drives resistance to immune-boosting therapies.

Prozac, a common antidepressant, appears to target glioblastoma, a difficult to treat, often deadly brain cancer, a new study with mice shows.